ABSTRACT We have prepared cytoskeletons from normal and Rous sarcoma virus-transformed cells by extraction with nonionic detergents in a buffered salt solution designed to preserve the structure as it exists in vivo. Virtually all of the phosphoprotein pp6Osrc in the cell is bound to such cytoskeletons. Furthermore, when these cytoskeletons are incubated in situ with pp6Osrc is phosphorylated. Labeling of other apparently transformation-specific cytoskeletal phosphoproteins is also observed. These results directly demonstrate an association between pp6Osrc and elements ofthe cytoskeleton and suggest that pp60src may exert at least some of its effects as a consequence of its interaction with this cellular framework. Rous sarcoma virus (RSV) efficiently infects and transforms fibroblasts in culture, and it causes sarcomas when injected into chickens. The transformation of cultured fibroblasts results in a number of changes affecting cell morphology, motility, metabolism, and growth regulation. All of these alterations from normal cell behavior appear to be due to the expression in infected cells of a single viral genetic element, the src gene (1). This gene codes for a phosphoprotein of molecular weight (Mr) 60,000 (pp608rc), which can be immunoprecipitated from RSV-infected cells with serum taken from rabbits bearing RSV-induced tumors (TBR serum) (2). A growing body of evidence indicates that pp6Osrc is a protein kinase (ATP:protein phosphotransferase, EC 2.7.1.37) (3-7) with the unusual property of phosphorylating tyrosine, rather than serine or threonine, residues (8). Although some cellular polypeptides have been identified that may be substrates for pp60src kinase activity (8, 9) , their function in the cell remains unknown. Immunofluorescent (10) and electron microscopic (11) studies have indicated a cytoplasmic localization of pp6Osrc, with some concentration at the inner surface of the plasma membrane, particularly at gap junctions between cells, and under ruffles. Evidence has also been presented (12) for the existence of a "signal sequence" (13, 14) in pp60src translated in vitro from virion RNA. Although this observation cannot predict the distribution of pp6Osrc between the particulate and soluble fractions of the cell in vivo, it does indicate that the mRNA for pp6O"rc may code for a protein with the capacity to interact with membranes. In fact, substantial amounts of pp6osrc are found to be membrane-associated when cells are ruptured by homogenization or sonication (15). Nevertheless, these fractionation procedures result in the release of roughly half of pp6osrc in soluble form (6). Thus, it has appeared there might be two forms of pp6Osrc in the cell: one soluble form free in the cytoplasm and a second form associated with the inner surface of the plasma membrane, perhaps as an integral membrane protein. We report here a finding that provides an alternative explanation for this behavior.
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It has become apparent in recent years that the cytoplasm of mammalian cells is organized by a cytoskeletal framework (16) (17) (18) . Elements of this cytoskeletal network make intimate connections with both the plasma membrane and the nuclear lamina (19) (20) (21) (22) . This structure can be largely preserved when cells are extracted with nonionic detergents such as Triton X-100 or Nonidet P40 (23) (24) (25) (26) (27) (28) (29) .
We have extracted monolayer cultures of RSV-transformed chicken embryo fibroblasts with 1% Nonidet P40 in a buffered salt solution designed to preserve the cytoskeleton and its associated elements in a functional form.* Under these extraction conditions, approximately 75% of cytoplasmic protein is released in soluble form (28, 30) , but virtually all of pp6osrc remains bound to the residual cytoskeletal structures on the culture dish. When such cytoskeletons are incubated with ['y-32P]ATP in situ, phosphorylation of pp60srC is observed. In addition, we see transformation-related labeling of other cytoskeletal phosphoproteins.
The approach presented in this report provides a novel way of studying both the biochemical and positional aspects of the interaction of pp60sC with potential substrates in the transformed cell. (28, 30) , and the insoluble cytoskeletal fraction. A whole-mount electron micrograph of the cytoskeletal structure remaining attached to the culture substratum after extraction of chicken embryo fibroblasts with CSK extraction buffer is shown in Fig. 1 . This structure resembles the structures seen by Wolosewick and Porter in high-voltage electron microscopy of whole cells (16) .
MATERIALS AND METHODS
The cytoskeletal structure remaining attached to the dish can be dissolved in a second detergent solution, RIPA lysis buffer. This mixture of Triton X-100, sodium deoxycholate, and NaDodSO4 was developed by Gilead et al. (35) to strike a balance between maximal solubilization of cellular protein and full retention of antigenic reactivity. Fig. 2 shows the results of an experiment in which we assayed boththe soluble and RIPA-solubilized cytoskeletal fractions of RSV-transformed chicken embryo fibroblasts for their relative content of pp60srC kinase activity. The amount of pp6OsC kinase activity present in each fraction was determined by im-
Cytoskeletal association of pp6Osrc kinase activity. A 15-cm plate of nd RSV-infected chicken embryo fibroblasts (approximately 107 cells) was washed at 0°C twice with phosphate-buffered saline, and twice with cytoskeletal buffer without detergent and then was extracted for 1 min at 0°C with 5 ml of cytoskeletal buffer containing 1% Nonidet P40 (CSK extraction buffer). The soluble fraction thus obtained was pipetted from the dish and centrifuged for 1 min at 12,000 X g to remove any insoluble debris, and the supernatant fraction was set aside on ice. The cytoskeleton left on the dish was washed twice with 10 ml of CSK extraction buffer, then dissolved in 5 ml of RIPA lysis buffer. The RIPA-solubilized cytoskeleton was also freed from any residual insoluble material by centrifugation at 12,000 X g for 1 min. Portions of both cytoskeletal and soluble fractions were then diluted 1:5 and 1:10 in RIPA and CSK extraction buffer, respectively. A soluble fraction from td RSV-infected cells was also prepared in the same way, and a second portion of the RIPA-solubilized cytoskeletal fraction from nd RSV-transformed cells was diluted 1:5 and 1:10 in this soluble fraction from td RSV-infected cells. Finally, a whole cell extract was made by dissolving a phosphate-buffered saline-washed, 15 -cm plate of nd RSV-transformed cells directly in 5 ml of RIPA lysis buffer. This whole cell RIPA extract was also clarified by centrifugation.
To assay for kinase activity, 0. The soluble fraction was then removed and set aside on ice. The cytoskeleton was washed twice with 1 ml of CSK extraction buffer, then dissolved in 500 Al of RIPA lysis buffer. In each case the cells on a second plate were dissolved directly in 1 ml of RIPA lysis buffer. All extracts were centrifuged for 1 min at 12,000 X g to remove any insoluble material, and then 0.2-ml aliquots were taken for immunoprecipitation with 10 MI of either TBR or normal rabbit serum. Immune complexes were precipitated with protein A-Sepharose beads, washed, and eluted from the beads with 100 Ml of NaDodSO4 sample buffer (36) . Samples (25 Ml) were then analyzed by electrophoresis on a 5-15% polyacrylamide gradient gel containing NaDodSO4. Gels were dried and labeled proteins were detected by autoradiography. Lanes [1] [2] [3] [4] [5] with 32P04 for 8 hr (a period that we have found gives optimal labeling of pp6O8rc), prepared soluble and cytoskeletal fractions as described above for the measurement of enzymatic activity, and immunoprecipitated both fractions with TBR or nonimmune serum. In Fig. 3, pp6Osrc is identified as the major 32P-labeled protein of Mr 60,000 present in TBR serum immunoprecipitates of transformed cells and absent from both TBR serum immunoprecipitates of td RSV-infected cells and nonimmune serum immunoprecipitates of RSV-infected cells. When the amount of 32P-labeled pp6osrc polypeptide immunoprecipitated from the cytoskeletal fraction is compared with that immunoprecipitated from the soluble fraction or from whole cells, it is apparent that, like the enzymatic activity, almost all the of 32P-labeled polypeptide is also associated with the cytoskeleton.
When RSV-and td RSV-infected cells are labeled for 8 hr with 32PO4, no differences are observed in the electropherograms of the 32PO4-labeled cytoskeletal proteins (data not shown). This is because pp6O1rc is a minor labeled species in these preparations and its presence is obscured by other phosphoproteins of approximately the same molecular weight. Thus, the presence of pp6O8rc in 32PO4-labeled cytoskeletons is revealed only by immunoprecipitation with TBR serum.
Kinase Activity in Cytoskeletal Preparations Assayed in Situ. Because the preceding experiments indicated that almost all of pp6Osrc is bound to elements of the cytoskeleton, it seemed possible that we might be able to assay its kinase activity in situ. (Amersham, specific activity >3000 Ci/mmol; 1 Ci = 3.7 X 1010 becquerels) at 100 MCi/mL Protein was precipitated by adding 1 ml of cold acetone. The pellet was dissolved in 200 ,ul of NaDodSO4 sample buffer. The cytoskeleton remaining attached to the dish was washed twice with 1 ml of CSK extraction buffer, then incubated with 100 Ml of the same buffer containing ['y-32P]ATP at 100 ,uCi/ml as described for the soluble fraction. After incubation, the incubation mixture was removed from the dish, and the cytoskeleton was dissolved in 500 M1 of NaDodSO4 sample buffer.gamples (25 ,ul) of soluble and cytoskeletal fractions were analyzed by electrophoresis as described in the legend to Fig. 3 . Radioactive bands were detected on dried gels by autoradiography with the aid of Lightning Plus intensifying screens parison, we incubated the soluble extracts of nontransformed and RSV-transformed cells with [ky-32P]ATP (Fig. 4B) , and at this level of resolution no differences were observed. Fig. 5 shows that the Mr 60,000 phosphoprotein labeled in situ in RSV-transformed cytoskeletons comigrates with authentic pp6OSC immunoprecipitated from 32PO4-labeled RSV-infected cells. Fig. 6A shows that this protein labeled in situ is also immunoprecipitated by TBR serum. We therefore conclude that one 9f the major phosphotransferase activities observed in situ with cytoskeletons of RSV-transformed cells is phosphorylation of pp6OsrC
In addition to the labeling of pp6Osrc, there are at least three additional consistent differences in the phosphoproteins labeled in situ in cytoskeletons of transformed and nontransformed cells. One such protein migrates as a band of about Mr 68,000 and is present only in cytoskeletons of transformed cells. Another easily and consistently observed difference in the phosphoproteins labeled in situ is the apparent absence of a species of approximate Mr 35,000 in cytoskeletons of transformed cells. Finally, a phosphoprotein of Mr 50,000, which specifically co-immunoprecipitates with pp6Otrc, is found only in the Ly-32P]ATP-labeled cytoskeletons of RSV-infected cells. This band at Mr 50,000 is revealed after longer exposure of the autoradiogram of Fig. 6A (Fig. 6B) .
Polyribosomes are a component of the cytoskeletal structure as studied here.* However, none of the phosphoproteins observed in these experiments are associated with polyribosomes. 
DISCUSSION
Binding of pp6Osrc to the Cytoskeleton. The principal finding of these experiments is that pp6OsrC is not released along with the soluble cellular proteins when cells are gently extracted with nonionic detergent in our CSK extraction buffer. Rather, pp6o0rc behaves as if it were an element of the cytoskeleton. We believe that this reflects the true state of pp60srC in vvo and is not the result of artifactual binding. The immunochemical localization of pp6O-9c in intact cells described by Rohrschneider (10) and Willingham et al. (11) indicates that pp6osrc is not freely diffusing in the cytoplasm and must therefore be attached to some substructure.
Phosphorylation of Cytoskeletal pp6Osrc in Situ. A second major finding of this study is that pp6osrc is phosphorylated in situ when our cytoskeletal preparations are incubated with ['y-32P]ATP. Because pp6osrc is not one of the major phosphoproteins in the cytoskeleton, we have considered a number of possible explanations for the fact that it is labeled so prominently in situ: (i) many cytoskeletal phosphoproteins may be phosphorylated/dephosphorylated by kinases and phosphatases, which are not themselves bound to the cytoskeleton and are thus removed during lysis of the cell and subsequent washing of the cytoskeleton; ( (Fig. 6B) . Similarly, a phosphoprotein of Mr 50,000 specifically coimmunoprecipitates with pp6Osrc from cells labeled in vio with 32PO4 (Fig. 3 ). Hunter and Sefton (8) have also identified a host cell phosphoprotein of similar molecular weight, which specifically co-immunoprecipitates with pp60src. It seems likely that their protein specifically co-immunoprecipitates with pp60a'c as a consequence of its association with pp60src in vivo, and not because it shares any antigenic determinants with pp6O8aC. Because Hunter and Sefton have further shown that this protein is phosphorylated on a tyrosine residue, this protein may be a substrate for the kinase activity of pp6Osrc. If the Mr 50,000 species we observe is the same as the protein of Hunter and Sefton, we may conclude that pp60)8rc has a substrate in the cytoskeletal structures.
Radke and Martin (9) have identified a protein of Mr 36,000 that is phosphorylated only in RSV-transformed cells. We do not observe a similarly sized protein prominently labeled in situ in cytoskeletons of transformed cells. In fact, we see the reverse: a protein of roughly Mr 36 ,000 is labeled in nontransformed cell cytoskeletons and is missing or much reduced in transformed cell cytoskeletons (Fig. 5A ). As discussed above, the results of labeling proteins in situ in cytoskeletons are not directly comparable to those obtained by labeling cells in vivo. Therefore, we do not rule out the possibility that these two proteins are the same.
We also observe transformation-specific labeling in situ of a phosphoprotein of Mr 68,000 in cytoskeletons of RSV-transformed cells. We are not aware of any previous reports of transformation-related proteins or of possible substrates for pp6osrc kinase activity of this size.
ppfjOSrC the Cytoskeletal Structures, and Transformation. Among the most obvious features of RSV-transformed cells are the alterations in cell morphology and motility. The altered sensitivity of RSV-transformed cells to serum growth factors, and the growth inhibitory effects of high cell density, can also be related to alterations in cytoskeletal organization (19, 20, (37) (38) (39) (40) . It has thus been only natural to speculate that pp6Osrc might have as a primary substrate some element(s) of the cytoskeletal system (3, 20, 38, 40) . The results presented here directly demonstrate that pp6O8sc itself is associated with cytoskeletal structures.
Furthermore, the three transformation-specific phosphoproteins that we have observed being phosphorylated in cytoskeletal structures in situ may be of fundamental importance to the transformation process.
Note Added in Proof. In recent experiments we have found that optimal labeling of cytoskeletal pp608rC and the Mr 68,000 protein by ['y-32P]ATP in situ is observed when the incubation is carried out for
